(Q64355658)

English

ApoE genotyping as a progression-rate biomarker in phase II disease-modification trials for Alzheimer's disease

scientific article published on 08 December 2009

In more languages
default for all languages
No label defined

No description defined

Statements

ApoE genotyping as a progression-rate biomarker in phase II disease-modification trials for Alzheimer's disease (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit